USA FINANCIAL FORMULAS’s Bristol-Myers Squibb BMY Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Buy	+4,554	New	+$261K	0.05%	109

Other funds holding BMY

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

USA FINANCIAL FORMULAS's BMY Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,554 shares worth $262K. The stake represents 0.05% of the portfolio and ranks #109 among its holdings.

1,309 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

USA FINANCIAL FORMULAS held 4,554 shares of Bristol-Myers Squibb worth $262K as of Q2 2026.
Bristol-Myers Squibb was a new USA FINANCIAL FORMULAS position in Q2 2026.
Bristol-Myers Squibb made up 0.05% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #109 holding.
1,309 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.